Background The availability of safe and effective COVID‐19 vaccines has enabled
protections against serious COVID‐19 outcomes, which are particularly important for …

Importance Patients with cancer are at increased risk for severe COVID-19, but it is unknown
whether SARS-CoV-2 vaccination is effective for them. Objective To determine the …

Background With the rapid evolution of the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) pandemic, the development of effective and safe vaccines was of utmost …

Clinical Practice Points• Patients with primary thoracic malignancies are at increased risk of
complications and death from COVID-19. Multiple studies have demonstrated humoral …

We investigated the association of SARS CoV-2 vaccination with COVID-19 severity in a
longitudinal study of adult cancer patients with COVID-19. A total of 1610 patients who were …

Background Cancer patients have increased morbidity and mortality from COVID‐19, but
may respond poorly to vaccination. The Evaluation of COVID‐19 Vaccination Efficacy and …

Introduction Coronavirus disease 2019 resulted in a 30% mortality rate in patients with
thoracic cancer. Given that patients with cancer were excluded from serum antisevere acute …

Importance Patients with cancer are known to have increased risk of COVID-19
complications, including death. Objective To determine the association of COVID-19 …

Given the rapidly expanding global spread of the SARS-Co-V-2 virus and the expanding
number of individuals with the serious and potentially fatal illness, COVID-19, there is an …

Background Patients with cancer are at high risk of severe or lethal COVID-19. The impact of
SARS-COV-2 vaccination on the risk of developing COVID-19 was investigated in an …